ЛЕЧЕНИЕ ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ И АНЕМИЕЙ ИЛИ ДЕФИЦИТОМ ЖЕЛЕЗА

Darya Valchuk; Oleksii Khaniukov; Liudmyla Pesotskaia; Liudmyla Sapozhnychenko; Olena Shchukina

doi:10.30888/2663-5712.2022-11-03-029

Authors

Darya Valchuk Dnipro State Medical University https://orcid.org/0000-0003-3847-5266
Oleksii Khaniukov Dnipro State Medical University https://orcid.org/0000-0003-4146-0110
Liudmyla Pesotskaia Dnipro State Medical University https://orcid.org/0000-0002-0784-1465
Liudmyla Sapozhnychenko Dnipro State Medical University https://orcid.org/0000-0002-6472-2235
Olena Shchukina Dnipro State Medical University https://orcid.org/0000-0002-9543-1545

DOI:

https://doi.org/10.30888/2663-5712.2022-11-03-029

Keywords:

anemia, iron deficiency, chronic heart failure, treatment.

Abstract

Anemia and iron deficiency is widespread among patients with chronic heart failure (CHF) and is associated in such patients with reduced ability to exercise, a deterioration in the quality of life and a worse prognosis, regardless of the presence of anem

Metrics

Metrics Loading ...

References

Gonzalez-Costello, J. et al. (2020) ‘Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidence’, European Journal of Internal Medicine, 80(March), pp. 91–98. doi: 10.1016/j.ejim.2020.04.031.

Anker, S. D. et al. (2009) ‘Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency’, New England Journal of Medicine, 361(25), pp. 2436–2448. doi: 10.1056/nejmoa0908355.

Ponikowski, P. et al. (2015) ‘Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency’, European Heart Journal, 36(11), pp. 657–668. doi: 10.1093/eurheartj/ehu385.

Jankowska, E. A. et al. (2015) ‘Effects of Intravenous Iron Therapy in Iron Deficient Patients With Systolic Heart Failure: Meta-Analysis of Randomized Control Trials’, Journal of the American College of Cardiology, 65(10), p. A854. doi: 10.1016/s0735-1097(15)60854-3.

Walther, C. P., Triozzi, J. L. and Deswal, A. (2020) ‘Iron deficiency and iron therapy in heart failure and chronic kidney disease’, Current opinion in nephrology and hypertension, 29(5), pp. 508–514. doi: 10.1097/MNH.0000000000000630.

Yancy, C. W. et al. (2017) 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of Amer, Circulation. doi: 10.1161/CIR.0000000000000509.

Ponikowski, P. et al. (2016) ‘2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure’, European Heart Journal, 37(27), pp. 2129-2200m. doi: 10.1093/eurheartj/ehw128.

Ezekowitz, J. A. et al. (2017) ‘2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure’, Canadian Journal of Cardiology, 33(11), pp. 1342–1433. doi: 10.1016/j.cjca.2017.08.022.

Ponikowski, P. et al. (2020) ‘Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial’, The Lancet, 396(10266), pp. 1895–1904. doi: 10.1016/S0140-6736(20)32339-4.

Vifor Pharma Ltd. Ferinject (ferric carboxymaltose). Summary of Product Characteristics. https://www.medicines.org.uk/emc/medicine/24167/SPC/Ferinject. (3 August 2018)

Magrì, D. et al. (2019) ‘Anemia and Iron Deficiency in Heart Failure: Clinical and Prognostic Role’, Heart Failure Clinics, 15(3), pp. 359–369. doi: 10.1016/j.hfc.2019.02.005.

McDonagh, T. et al. (2018) ‘Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice’, European Journal of Heart Failure, 20(12), pp. 1664–1672. doi: 10.1002/ejhf.1305.

Lewis, G.D. et al. (2017) ' Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial', The Journal of the American medical assosiation, 317(19), p.1958-1966, doi: 10.1001/jama.2017.5427